The Oxylipin Response as a New PrEdictive Biomarker of Patient Responsiveness to Biotherapy in Rheumatoid Arthritis (OPERA)
Clinical trial NCT05552105 · COMPLETED
Trial details
- NCT number
- NCT05552105
- Sponsor
- University Hospital, Clermont-Ferrand
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2025-01-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.